Clinical Trials Ontology
How to cite this record FAIRsharing.org: CTO; Clinical Trials Ontology; DOI: https://doi.org/10.25504/FAIRsharing.qp211a; Last edited: Jan. 8, 2019, 1:32 p.m.; Last accessed: Apr 21 2021 6:31 p.m.
Record added: Oct. 24, 2017, 9:41 a.m.
Record updated: Feb. 6, 2018, 8:25 p.m. by The FAIRsharing Team.
Edits to 'https://fairsharing.org/FAIRsharing.qp211a' by 'The FAIRsharing Team' at 20:19, 06 Feb 2018 (approved): 'description' has been modified: Before: The CTO-NDD stands for Clinical Trial Ontology-Neurodegenerative Diseases, which was built with the purpose of organizing the knowledge domain of clinical trials in neurodegeneration field. This resource has been created for use in the IMI-funded AETIONOMY project (www.aetionomy.org). After: The Clinical Trials Ontology (CTO) is also known as the Clinical Trial Ontology-Neurodegenerative Diseases (CTO-NDD), and describes clinical trials in the field of neurodegeneration. This resource has been created for use in the IMI-funded AETIONOMY project (www.aetionomy.org).
No XSD schemas defined
Conditions of Use
No publications available
View in BioPortal.
No guidelines defined
Models and Formats
No syntax standards defined
No identifier schema standards defined
No metrics standards defined
No Related Databases
This record is not implemented by any policy.
This record is in need of a maintainer. If you login, you'll be able to claim this record.